Intradermal DNA Vaccination Enhanced by Low-Current Electroporation Improves Antigen Expression and Induces Robust Cellular and Humoral Immune Responses

DNA represents an ideal vaccine platform for HIV and many infectious diseases because of its safety, stability, and ease of manufacture. However, the immunogenicity of DNA vaccines has traditionally been low compared with viral vectors, recombinant protein, and live attenuated vaccines. The immunoge...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hutnick, Natalie A., Myles, Devin J.F., Ferraro, Bernadette, Lucke, Colleen, Lin, Feng, Yan, Jian, Broderick, Kate E., Khan, Amir S., Sardesai, Niranjian Y., Weiner, David B.
Formato: Artigo
Lenguaje:Inglês
Publicado: Mary Ann Liebert, Inc. 2012
Materias:
Research Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3440022/
https://ncbi.nlm.nih.gov/pubmed/22650607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2012.055
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares